97218 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
Sub-classes:PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES
#2BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS
#3ANTIBODY REPURPOSING
#4METHOD AND MEANS FOR ENHANCING THERAPEUTIC ANTIBODIES
#5ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF
#6ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF
#7Albumin-Binding Polypeptides and Uses Thereof
#8ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#9ANTI-CAR COMPOSITIONS AND METHODS
#10FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES
#11COMPOSITIONS AND METHODS FOR TREATING PEDIATRIC MYASTHENIA GRAVIS
#12ANTI-IDIOTYPE ANTIBODY MOLECULES AND USES THEREOF
#13ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF
#14Anti-TIGIT Antibodies
#15Anti-TIGIT Antibodies
#16ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF CARGO PROTEIN
#17PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES
#18ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF
#19SINGLE-AND MULTI-CHAIN POLYPEPTIDES THAT BIND SPECIFICALLY TO CD3 EPSILON
#20ANTI-IDIOTYPIC ANTIBODIES TO BCMA-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#21Antigen binding molecules specific for an anti-CD19 scFV
#22COMPOSITIONS AND METHODS FOR IMPROVING TUMOR PENETRATION OF TUMOR SPECIFIC ANTIBODIES
#23PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES
#24METHODS FOR REDUCING TOXICITY OF A CHEMOTHERAPEUTIC DRUG
#25Nucleic acids encoding polypeptides against IL-23
#26ANTI-CAR COMPOSITIONS AND METHODS
#27Antigen binding molecules specific for an anti-CD19 scFv
#28HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE
#29REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF
#30Broad-spectrum monoclonal anti-flu B antibody and uses thereof
#31Anti-TIGIT antibodies
#32BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS
#33Protease-activated T cell bispecific molecules
#34Anti-TIGIT antibodies
#35Methods for reducing toxicity of a chemotherapeutic drug
#36Antagonistic Antibodies Specifically Binding Human CD40 and Methods of Use
#37Polypeptides against IL-23
#38ANTI-CD19 scFv (FMC63) POLYPEPTIDE AND USES THEREOF
#39ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY
#40Antigen binding molecules specific for an anti-CD19 scFv
#41Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
#42ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#43ANTI-CD19 scFv (FMC63) POLYPEPTIDE
#44Agonistic antibodies specifically binding CD40 and methods of use
#45Anti-MIF immunohistochemistry
#46Compositions and methods for treatment of non-hodgkins lymphoma
#47Anti-CD19 scFv (FMC63) polypeptide
#48Recombinant polypeptide production
#49Antibody-binding peptide
#50Methods for identifying antibodies with reduced immunogenicity
#51IP-10 antibody dosage escalation regimens
#52Rapid generation of anti-idiotypic antibodies
#53Uses of monoclonial antibody 8H9
#54TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#55CYTOTOXIC ANTIBODIES DIRECTED AGAINST ANTIBODIES INHIBITING FACTOR VIII
#56Genus-wide chlamydial peptide vaccine antigens
#57Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
#58Variants of humanized anti-carcinoma MAb CC49
#59Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#60Uses of monoclonal antibody 8H9
#61CHAIN REACTION CREATING OLIGOMERS FROM REPEAT UNITS OF BINDING MOLECULES
#62Method for preparation of single chain antibodies
#63FUSION PROTEIN CONSTRUCTS
#64PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#65Measurement methods
#66TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#67IMMUNOASSAY DEVICE AND METHOD
#68Reagents and methods for inducing an immune response to prostate specific antigen
#69Cytotoxic antibodies directed against antibodies inhibiting factor VIII
#70Compositions and methods for treatment of cervical cancer
#71INTERNAL IMAGE ANTIBODIES FOR OPTICAL IMAGING AND THERAPY
#72Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules
#73METHOD FOR PRODUCING ANTI-IDIOTYPIC ANTIBODIES
#74Conjugate and its use as a standard in an immunoassay
#75Variants of humanized anti-carcinoma MAb CC49
#76PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#77PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#78Method for generating anti-variable region monoclonal antibodies
#79Toxin-related antibodies with antimicrobial and antiviral activity
#80Compositions and methods for treatment of non-hodgkins lymphoma
#81Anti-idiotype antibody, method of constructing the anti-idiotype antibody, and method of preparing idiotype antibody using the anti-idiotype antibody
#82Heterodimeric protein binding compositions
#83Measurement methods
#84Reagents and methods for inducing an immune response to prostate specific antigen
#85Variants of humanized anti-carcinoma monoclonal antibody CC49
#86Uses of monoclonal antibody 8H9
#87Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
#88Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
#89Trans-membrane-antibody induced inhibition of apoptosis